Why this grouping
MONDO alignment & provenance
closeMatch: the grouping corresponds to the MONDO Niemann-Pick disease class, but is implemented as an explicit curated subset of current dismech Disease entries.
MONDO consistency: consistent Listed members are MONDO Niemann-Pick disease type A, chronic neurovisceral ASMD/type A-B, type B, type C, and the historical type E entries. Niemann-Pick disease type D is not separately curated: it has been resolved as an NPC1 founder haplotype (Nova Scotia) and is covered by the type C member.
Membership criteria
- OR
- HAS PHENOTYPE
Hepatosplenomegaly HP:0001433
Hepatosplenomegaly.
- HAS PHENOTYPE
Hepatomegaly HP:0002240
Hepatomegaly.
- HAS PHENOTYPE
Splenomegaly HP:0001744
Splenomegaly.
- HAS PHENOTYPE
Neurodegeneration HP:0002180
Neurodegeneration.
- HAS PHENOTYPE
Vertical supranuclear gaze palsy HP:0000511
Vertical supranuclear gaze palsy.
- HAS PHENOTYPE
Hepatosplenomegaly HP:0001433
Coverage and gaps
No exact MONDO mapping is declared, so MONDO descendant gaps are not inferred for this grouping.
| Status | DisMech entry | MONDO concept | In DisMech | Has MONDO ID | In grouping MONDO | Member state | Conditions satisfied | C1.1 Hepatosplenomegaly. HP:0001433 | C1.2 Hepatomegaly. HP:0002240 | C1.3 Splenomegaly. HP:0001744 | C1.4 Neurodegeneration. HP:0002180 | C1.5 Vertical supranuclear gaze palsy. HP:0000511 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| listed with MONDO ID |
Niemann-Pick Disease Type A
DISEASE
Differentiating mechanismSevere infantile neuronopathic acid sphingomyelinase deficiency caused by biallelic SMPD1 variants with profound enzyme deficiency, lysosomal sphingomyelin storage, early hepatosplenomegaly, cherry-red macular spots, and rapidly fatal neurodegeneration.
SMPD1 hgnc:11120
|
Niemann-Pick disease type A
MONDO:0009756
|
yes | yes | not assessed | listed | satisfied | SATISFIED | SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Niemann-Pick Disease Type B
DISEASE
Differentiating mechanismChronic non-neuronopathic visceral acid sphingomyelinase deficiency caused by biallelic SMPD1 variants with residual enzyme activity, producing hepatosplenomegaly, interstitial lung disease, cytopenias, dyslipidemia, growth delay, and survival often into adulthood.
SMPD1 hgnc:11120
|
Niemann-Pick disease type B
MONDO:0011871
|
yes | yes | not assessed | listed | satisfied | SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Niemann-Pick Disease Type C
DISEASE
Differentiating mechanismNPC1/NPC2-related lysosomal cholesterol egress failure, distinct from acid sphingomyelinase deficiency, with unesterified cholesterol and secondary glycosphingolipid storage causing neonatal visceral disease or progressive neurologic disease with vertical supranuclear gaze palsy, ataxia, dysphagia, dystonia, seizures, and psychiatric features.
NPC1 hgnc:7897
NPC2-related type C disease accounts for a smaller subset of NPD-C and disrupts the soluble lysosomal cholesterol-transfer partner of NPC1, producing the same cholesterol-egress failure and secondary lipid storage phenotype.
NPC2 hgnc:14537
|
Niemann-Pick disease type C
MONDO:0018982
|
yes | yes | not assessed | listed | satisfied | SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | SATISFIED |
| listed with MONDO ID |
Niemann-Pick Disease Type E
DISEASE
Differentiating mechanismA historical, molecularly unresolved Niemann-Pick label applied to rare (mostly adult) patients with hepatomegaly, foamy-macrophage tissue infiltration, sphingomyelin storage, and only partial acid sphingomyelinase deficiency who fitted neither type A/B nor type C. It is differentiated from the other members not by a distinct gene but by the absence of one: in the molecular era these cases are re-assignable to SMPD1-related ASMD or to NPC1/NPC2 disease, so the entry is retained as a nosologic-history member rather than as a separate disease mechanism.
|
Niemann-Pick disease type E
MONDO:0020384
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Chronic Neurovisceral Acid Sphingomyelinase Deficiency
DISEASE
Differentiating mechanismIntermediate chronic neurovisceral acid sphingomyelinase deficiency, historically Niemann-Pick disease type A/B, caused by biallelic SMPD1 variants with residual acid sphingomyelinase activity and combined chronic visceral disease plus mild to severe neurologic involvement.
SMPD1 hgnc:11120
|
chronic neurovisceral acid sphingomyelinase deficiency
MONDO:0850058
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED |
Source
View YAML on GitHubRaw YAML
name: Niemann-Pick Diseases
display_name: Niemann-Pick Diseases
creation_date: "2026-06-14T00:00:00Z"
description: >-
A curated grouping of explicit Niemann-Pick disease entries spanning the
acid sphingomyelinase deficiency branch (SMPD1-related types A, A/B, and B)
and the cholesterol-trafficking branch (NPC1/NPC2-related type C). Members
share lysosomal lipid storage with overlapping hepatosplenomegaly, pulmonary,
ocular, neurologic, and visceral manifestations, but differ sharply in primary
gene, stored lipid, neuronopathic burden, and treatment implications.
grouping_basis:
- SHARED_MECHANISM
- SHARED_PHENOTYPE
grouping_rationale: >-
Grouped as an explicit curated union of Disease entries named as
Niemann-Pick disease types or direct modern subtype equivalents, not as all
sphingolipidoses or all lysosomal storage disorders. Types A, A/B, and B are
SMPD1-related acid sphingomyelinase deficiency disorders with sphingomyelin
storage and variable neuronopathic involvement, whereas type C is an NPC1/NPC2
cholesterol egress disorder with secondary sphingolipid storage and
progressive neurovisceral disease. The shared boundary is historical and
clinical as well as mechanistic: each member has lysosomal lipid storage and
overlapping hepatosplenomegaly or neurovisceral features, but the grouping
excludes unrelated Pick disease frontotemporal degeneration and other
lysosomal storage diseases unless a standalone entry is explicitly curated as
a Niemann-Pick disease.
mappings:
mondo_mappings:
- term:
id: MONDO:0001982
label: Niemann-Pick disease
mapping_predicate: skos:closeMatch
mapping_source: MONDO
mapping_justification: >-
closeMatch: the grouping corresponds to the MONDO Niemann-Pick disease
class, but is implemented as an explicit curated subset of current
dismech Disease entries.
consistency:
- reference: MONDO
consistent: CONSISTENT
notes: >-
Listed members are MONDO Niemann-Pick disease type A, chronic
neurovisceral ASMD/type A-B, type B, type C, and the historical type E
entries. Niemann-Pick disease type D is not separately curated: it has
been resolved as an NPC1 founder haplotype (Nova Scotia) and is covered
by the type C member.
membership_criteria:
- description: >-
A member is an explicit Niemann-Pick disease entry with lysosomal lipid
storage and at least one characteristic shared clinical feature such as
hepatosplenomegaly, hepatomegaly, splenomegaly, neurodegeneration, or
vertical supranuclear gaze palsy.
criteria_semantics: NECESSARY
logic:
operator: OR
operands:
- criterion_predicate: HAS_PHENOTYPE
description: Hepatosplenomegaly.
phenotype_term:
preferred_term: Hepatosplenomegaly
term:
id: HP:0001433
label: Hepatosplenomegaly
- criterion_predicate: HAS_PHENOTYPE
description: Hepatomegaly.
phenotype_term:
preferred_term: Hepatomegaly
term:
id: HP:0002240
label: Hepatomegaly
- criterion_predicate: HAS_PHENOTYPE
description: Splenomegaly.
phenotype_term:
preferred_term: Splenomegaly
term:
id: HP:0001744
label: Splenomegaly
- criterion_predicate: HAS_PHENOTYPE
description: Neurodegeneration.
phenotype_term:
preferred_term: Neurodegeneration
term:
id: HP:0002180
label: Neurodegeneration
- criterion_predicate: HAS_PHENOTYPE
description: Vertical supranuclear gaze palsy.
phenotype_term:
preferred_term: Vertical supranuclear gaze palsy
term:
id: HP:0000511
label: Vertical supranuclear gaze palsy
members:
- member: Niemann-Pick Disease Type A
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Severe infantile neuronopathic acid sphingomyelinase deficiency caused by
biallelic SMPD1 variants with profound enzyme deficiency, lysosomal
sphingomyelin storage, early hepatosplenomegaly, cherry-red macular spots,
and rapidly fatal neurodegeneration.
gene:
preferred_term: SMPD1
term:
id: hgnc:11120
label: SMPD1
- member: Niemann-Pick Disease Type B
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Chronic non-neuronopathic visceral acid sphingomyelinase deficiency caused
by biallelic SMPD1 variants with residual enzyme activity, producing
hepatosplenomegaly, interstitial lung disease, cytopenias, dyslipidemia,
growth delay, and survival often into adulthood.
gene:
preferred_term: SMPD1
term:
id: hgnc:11120
label: SMPD1
- member: Chronic Neurovisceral Acid Sphingomyelinase Deficiency
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Intermediate chronic neurovisceral acid sphingomyelinase deficiency,
historically Niemann-Pick disease type A/B, caused by biallelic SMPD1
variants with residual acid sphingomyelinase activity and combined
chronic visceral disease plus mild to severe neurologic involvement.
gene:
preferred_term: SMPD1
term:
id: hgnc:11120
label: SMPD1
- member: Niemann-Pick Disease Type C
member_type: DISEASE
differentiating_mechanisms:
- description: >-
NPC1/NPC2-related lysosomal cholesterol egress failure, distinct from
acid sphingomyelinase deficiency, with unesterified cholesterol and
secondary glycosphingolipid storage causing neonatal visceral disease or
progressive neurologic disease with vertical supranuclear gaze palsy,
ataxia, dysphagia, dystonia, seizures, and psychiatric features.
gene:
preferred_term: NPC1
term:
id: hgnc:7897
label: NPC1
- description: >-
NPC2-related type C disease accounts for a smaller subset of NPD-C and
disrupts the soluble lysosomal cholesterol-transfer partner of NPC1,
producing the same cholesterol-egress failure and secondary lipid storage
phenotype.
gene:
preferred_term: NPC2
term:
id: hgnc:14537
label: NPC2
- member: Niemann-Pick Disease Type E
member_type: DISEASE
differentiating_mechanisms:
- description: >-
A historical, molecularly unresolved Niemann-Pick label applied to rare
(mostly adult) patients with hepatomegaly, foamy-macrophage tissue
infiltration, sphingomyelin storage, and only partial acid
sphingomyelinase deficiency who fitted neither type A/B nor type C. It is
differentiated from the other members not by a distinct gene but by the
absence of one: in the molecular era these cases are re-assignable to
SMPD1-related ASMD or to NPC1/NPC2 disease, so the entry is retained as a
nosologic-history member rather than as a separate disease mechanism.
notes: >-
Exclude Pick disease/frontotemporal lobar degeneration, Gaucher disease,
Tay-Sachs disease, Sandhoff disease, Salla disease, and broad lysosomal
storage or sphingolipidosis entries unless the disease entry is explicitly a
Niemann-Pick disease. Niemann-Pick disease type E is listed as a
nosologic-history member: it names a historical residual category rather than
a distinct molecular disease, and satisfies the grouping criteria through
hepatomegaly and neurodegeneration.